Nebula Caravel Acquisition Corp. (NASDAQ:NEBC) shareholders have approved its combination with dog-walking app Rover at a special meeting July 28.
The deal was overwhelmingly approved, but Nebula Caravel’s press release and 8-K filing did not reveal redemption figures. The materials noted, however, that the deal would bring $240 million in net proceeds to upon completion and Rover expected at the time of the deal announcement to add $250 million to its balance sheet through the transaction. This would appear to make it one of the smoother votes of the week as the down market has made the de-SPAC endgame difficult for many others.
Nebula Caravel expects to close the deal July 30, after which the combined company’s shares and warrants will commence trading on Nasdaq under the ticker symbols “ROVR” and “ROVRW” August 2.
The parties initially announced the $1.35 billion deal on February 11. Rover connects consumers with local pet-sitters, walkers and groomers via an online marketplace and has thus far facilitated services between 500,000 pet care providers and 2 million pet owners.
Nebula Caravel and Rover joined SPACInsider for a live Q&A webinar on March 31. All other proposals related to the business combination were approved by shareholders. For a full list of proposals and vote tallies, click HERE.
ADVISORS
- Morgan Stanley & Co. LLC is acting as exclusive financial advisor to Rover.
- Wilson Sonsini Goodrich & Rosati is acting as legal advisor to Rover.
- Deutsche Bank Securities acted as lead financial advisor, capital markets advisor and private placement agent to Nebula Caravel Acquisition Corp.
- William Blair & Co., LLC and Stifel Financial Corp., also acted as capital markets advisor and private placement agents to Nebula Caravel Acquisition Corp.
- Simpson Thacher & Bartlett LLP is acting as legal advisor to Caravel.
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...
At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...